Colorized electron micrograph showing malaria parasite (right, blue) attaching to a human red blood cell. The inset shows a detail of the attachment point at higher magnification. Credit: NIAID Detecting…
Tag: Conditions
Biological agent trials for psoriasis rarely include patient images
Few randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in the Journal of Dermatological Treatment. Sam Polesie,…
Women with osteoporosis want to know their fracture risk
Most women with osteoporosis want to know their fracture risk, but only half have received this information from health care providers, according to a study published online Nov. 13 in…
Prone positioning does not cut time to weaning in ARDS with VV-ECMO
For patients with severe acute respiratory distress syndrome (ARDS) undergoing venovenous extracorporeal membrane oxygenation (VV-ECMO), prone positioning does not decrease the time to successful weaning compared with supine positioning, according…
Nirsevimab protects infants against RSV-linked hospitalization
Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New…
Emerging COVID variant is spreading ahead of the holidays. Are you still protected?
Credit: Pixabay/CC0 Public Domain For a third season, COVID-19 cases are rising ahead of the holidays, this time with a more recent variant driving infections. JN.1, a variant of omicron,…
SARS-CoV-2 rebound rate similar with, without oral antivirals
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rebound occurs at a similar rate for those receiving and not receiving oral antiviral treatment and for those receiving nirmatrelvir/ritonavir or placebo, according…
Is it COVID, flu, or allergies? How to protect yourself and loved ones this season
Credit: Tima Miroshnichenko from Pexels Flu season is here once again. And many questions have formed over the last couple of years about how you can stay safe from both…
Risk for vitiligo increased for transplant recipients
Transplant recipients, especially those receiving hematopoietic stem cell transplant (HSCT), have an increased risk for vitiligo, according to a brief report published online Dec. 13 in JAMA Dermatology. Chul Hwan…
Significant benefit seen in Phase III trial of experimental drug for kidney disease
Credit: Pixabay/CC0 Public Domain In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria—albumin in urine, a sign of kidney damage—for 50% of participants.…
